Literature DB >> 20153532

Multiple sclerosis - candidate mechanisms underlying CNS atrophy.

Volker Siffrin1, Johannes Vogt, Helena Radbruch, Robert Nitsch, Frauke Zipp.   

Abstract

Recently it has become clear that the neuronal compartment plays a more important role than previously thought in the pathology of multiple sclerosis. Apart from demyelination, neuronal pathology is apparently largely responsible for the brain atrophy that can be observed early on and throughout the course of the disease. The loss of axons and their neurons in the course of chronic neuroinflammation is a major factor determining long-term disability in patients. The actual steps leading from immune attack against the myelin sheath to neuronal damage are not yet fully clear. Here we review key findings about direct axonal damage processes, demyelination-related neuronal pathology and cell-body pathology, the major pathologic correlates that underlie brain atrophy in MS. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20153532     DOI: 10.1016/j.tins.2010.01.002

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  63 in total

1.  The problems and promises of research into human immunology and autoimmune disease.

Authors:  Bart O Roep; Jane Buckner; Stephen Sawcer; Rene Toes; Frauke Zipp
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

2.  Unusual patient with multiple sclerosis and shunt-responsive normal-pressure hydrocephalus.

Authors:  O Algin; O Taskapilioglu; B Hakyemez; M Parlak
Journal:  Clin Neuroradiol       Date:  2011-04-02       Impact factor: 3.649

3.  Brain atrophy in picornavirus-infected FVB mice is dependent on the H-2Db class I molecule.

Authors:  April M Huseby Kelcher; Pascal A Atanga; Jeffrey D Gamez; Luz M Cumba Garcia; Stephanie J Teclaw; Kevin D Pavelko; Slobodan I Macura; Aaron J Johnson
Journal:  FASEB J       Date:  2017-02-10       Impact factor: 5.191

Review 4.  Clinical relevance of brain volume measures in multiple sclerosis.

Authors:  Nicola De Stefano; Laura Airas; Nikolaos Grigoriadis; Heinrich P Mattle; Jonathan O'Riordan; Celia Oreja-Guevara; Finn Sellebjerg; Bruno Stankoff; Agata Walczak; Heinz Wiendl; Bernd C Kieseier
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

Review 5.  Response Heterogeneity With Exercise Training and Physical Activity Interventions Among Persons With Multiple Sclerosis.

Authors:  Jessica F Baird; Robert W Motl
Journal:  Neurorehabil Neural Repair       Date:  2018-12-26       Impact factor: 3.919

6.  Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging.

Authors:  Allan MacKenzie-Graham; Gilda A Rinek; Andrea Avedisian; Stefan M Gold; Andrew J Frew; Cynthia Aguilar; David R Lin; Elizabeth Umeda; Rhonda R Voskuhl; Jeffry R Alger
Journal:  Neuroimage       Date:  2011-12-13       Impact factor: 6.556

Review 7.  [Neuroprotection in the treatment of multiple sclerosis].

Authors:  F Zipp; R Gold
Journal:  Nervenarzt       Date:  2011-08       Impact factor: 1.214

8.  Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex.

Authors:  René-Maxime Gracien; Sarah C Reitz; Stephanie Michelle Hof; Vinzenz Fleischer; Hilga Zimmermann; Amgad Droby; Helmuth Steinmetz; Frauke Zipp; Ralf Deichmann; Johannes C Klein
Journal:  Eur Radiol       Date:  2015-10-22       Impact factor: 5.315

9.  Promoting return of function in multiple sclerosis: An integrated approach.

Authors:  Mar Gacias; Patrizia Casaccia
Journal:  Mult Scler Relat Disord       Date:  2013-10-01       Impact factor: 4.339

10.  Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies.

Authors:  Kathrin S Utz; De-Hyung Lee; Alexandra Lämmer; Anne Waschbisch; Ralf A Linker; Thomas Schenk
Journal:  Ther Adv Neurol Disord       Date:  2016-04-18       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.